Related by context. Frequent words. (Click for all words.) 68 placebo controlled clinical 67 Multicenter 67 Thrombolysis 66 Phase Ib clinical 65 multicentre 65 prospective observational 64 TRITON TIMI 64 double blinded placebo 64 Phase III randomized 64 Gynecologic Oncology Group 63 Acute Myocardial Infarction 63 multicenter randomized 63 phase IIb 62 multicenter 62 randomized Phase III 62 multicenter randomized double 62 phase IIa 62 RRMS patients 62 PRECiSE 61 Myocardial Infarction 61 placebo controlled randomized 61 Pirfenidone 60 prospective randomized controlled 60 Meta Analysis 60 randomized controlled clinical trials 60 Ischemic 60 tolvaptan 60 placebo controlled clinical trials 60 cardiac dysfunction 60 Clinical Trial Results 60 substudy 59 CA4P 59 Arch Intern Med 59 label multicenter 59 bosentan 59 tocilizumab 59 Desmoteplase 59 HALTS 59 EORTC 59 Pivotal Phase III 59 multicenter clinical 59 Apixaban 59 Pivotal Trial 58 Arch Neurol 58 Systemic Lupus Erythematosus 58 pertuzumab 58 intracerebral hemorrhage 58 #:#-# [031] 58 subgroup analyzes 58 #:#-# [029] 58 placebo controlled studies 58 elotuzumab 58 J Clin Oncol 58 nab paclitaxel 58 NSABP 58 RTOG 58 axitinib 58 prospective randomized 58 Acute Coronary Syndrome 58 Solid Tumors 58 liver transplant recipients 58 Phase 2a trial 58 randomized placebo controlled 58 Rosuvastatin 58 randomized controlled clinical 58 ALLHAT 58 hepatotoxicity 58 thrombotic events 58 RADIANT 57 ZD# [001] 57 SABCS 57 multicenter study 57 active comparator 57 placebo controlled trials 57 Catheterization 57 randomized clinical 57 ATTRACT 57 neoadjuvant 57 Pivotal Phase 57 Lancet Neurology 57 noninferiority 57 acute coronary syndromes ACS 57 blind randomized controlled 57 randomized controlled 57 hepatocellular carcinoma HCC 57 ADHF 57 DSMB 57 diabetic neuropathic pain 57 myocardial ischemia 57 left ventricular dysfunction 56 eszopiclone 56 carotid artery stenting 56 blinded placebo controlled 56 SWOG 56 Phase 2a clinical 56 muraglitazar 56 dabigatran etexilate 56 Pharmacokinetic 56 Phase III Trial 56 Rivaroxaban 56 pheochromocytoma